Valeo Pharma Inc. products

Hesperco capsules is Valeo`s unique hesperidin formulation and will be available in bottles of 60 capsules. Hesperidin is a bioflavonoid, with powerful antioxidant properties that help support the immune system.

The first Parkinson’s Disease (PD) treatment in Canada since 2006, providing relief of symptoms during the off-phase in dopamine treated patients.

Yondelis® (trabectedin) is a novel marine-derived antitumor agent manufactured by PharmaMar S.A., based in Madrid, Spain. It exerts its anticancer effects primarily by inhibiting active transcription, a type of gene expression on which proliferating cancer cells are particularly dependent.

Asthma is a chronic inflammatory disease that causes the airways in the lungs to narrow and swell. Symptoms include wheezing, breathlessness, chest tightness, cough and asthma attacks (exacerbations).

Next generation dual therapy LABA/ICS. Partner with Novartis Pharma Canada.